Cita APA

Fassio, E., Barreyro, F. J., Pérez, M. S., Dávila, D., Landeira, G., Gualano, G., & Ruffillo, G. (2022). Hepatocellular carcinoma in patients with metabolic dysfunctionassociated fatty liver disease: Can we stratify at-risk populations? Web

Citación estilo Chicago

Fassio, Eduardo, Fernando Javier Barreyro, Mariana Soledad Pérez, Diana Dávila, Graciela Landeira, Gisela Gualano, and Gabriela Ruffillo. Hepatocellular Carcinoma in Patients With Metabolic Dysfunctionassociated Fatty Liver Disease: Can We Stratify At-risk Populations? 2022.

Cita MLA

Fassio, Eduardo, et al. Hepatocellular Carcinoma in Patients With Metabolic Dysfunctionassociated Fatty Liver Disease: Can We Stratify At-risk Populations? 2022.